Your Article Summary
See Latest ArticlesNumber of shares and votes in Active Biotech
Active Biotech, 07/01/09
Active Biotech AB is a biotechnology company with focus on autoimmune/inflammatory diseases and cancer. Projects in pivotal phase are laquinimod, an orally administered small molecule with unique immunomodulatory properties for the treatment of multiple sclerosis, as well as ANYARA for use in cancer targeted therapy, primarily of renal cancer. Further key projects in clinical development comprise the three orally administered compounds TASQ for prostate cancer, 57-57 for SLE and RhuDex for RA.
Today in Biotechnology...keeping you current
Receive free subspecialty "5-minute updates" via email
Quality by Design for Biotechnology Products—Part 2
BioPharm, 12/09/09
Amylin Pharmaceuticals to Present at the 2009 Deutsche Bank Biotech Boston Confab
Amylin Pharmaceuticals, 12/09/09
PR distribution service for the biotech industry
b3c newswire, 12/07/09